NO20030243L - Nye forbindelser og deres anvendelse som glysintransportinhibitorer - Google Patents

Nye forbindelser og deres anvendelse som glysintransportinhibitorer

Info

Publication number
NO20030243L
NO20030243L NO20030243A NO20030243A NO20030243L NO 20030243 L NO20030243 L NO 20030243L NO 20030243 A NO20030243 A NO 20030243A NO 20030243 A NO20030243 A NO 20030243A NO 20030243 L NO20030243 L NO 20030243L
Authority
NO
Norway
Prior art keywords
new compounds
transport inhibitors
glycine transport
glycine
inhibitors
Prior art date
Application number
NO20030243A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030243D0 (no
Inventor
Ejner Knud Moltzen
Paul Garrick Smith
Christian Krog-Jensen
Klaus Peter Boegesoe
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20030243D0 publication Critical patent/NO20030243D0/no
Publication of NO20030243L publication Critical patent/NO20030243L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/14—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20030243A 2000-07-21 2003-01-17 Nye forbindelser og deres anvendelse som glysintransportinhibitorer NO20030243L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001124 2000-07-21
PCT/DK2001/000510 WO2002008216A1 (en) 2000-07-21 2001-07-19 Novel compounds and their use as glycine transport inhibitors

Publications (2)

Publication Number Publication Date
NO20030243D0 NO20030243D0 (no) 2003-01-17
NO20030243L true NO20030243L (no) 2003-03-06

Family

ID=8159626

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030243A NO20030243L (no) 2000-07-21 2003-01-17 Nye forbindelser og deres anvendelse som glysintransportinhibitorer

Country Status (28)

Country Link
US (1) US6921774B2 (de)
EP (1) EP1301502B1 (de)
JP (1) JP2004504393A (de)
KR (1) KR20030015889A (de)
CN (1) CN100509791C (de)
AR (1) AR032358A1 (de)
AT (1) ATE295844T1 (de)
AU (2) AU2001281740B2 (de)
BG (1) BG107530A (de)
BR (1) BR0113011A (de)
CA (1) CA2416447A1 (de)
CZ (1) CZ2003396A3 (de)
DE (1) DE60110914T2 (de)
EA (1) EA005621B1 (de)
ES (1) ES2238466T3 (de)
HR (1) HRP20030053A2 (de)
HU (1) HUP0302778A3 (de)
IL (2) IL153988A0 (de)
IS (1) IS6693A (de)
MX (1) MXPA03000642A (de)
NO (1) NO20030243L (de)
NZ (1) NZ523720A (de)
PL (1) PL364439A1 (de)
PT (1) PT1301502E (de)
SK (1) SK2022003A3 (de)
UA (1) UA75081C2 (de)
WO (1) WO2002008216A1 (de)
ZA (1) ZA200300514B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006524642A (ja) * 2003-04-30 2006-11-02 ハー・ルンドベック・アクチエゼルスカベット 芳香族オキシフェニルおよび芳香族スルファニルフェニル誘導体
CA2536275A1 (en) * 2003-08-21 2005-03-03 H. Lundbeck A/S The combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression
US7163954B2 (en) * 2003-09-25 2007-01-16 Wyeth Substituted naphthyl benzothiophene acids
JP2007528879A (ja) * 2004-03-12 2007-10-18 ハー・ルンドベック・アクチエゼルスカベット フェニルインダン誘導体
WO2005100301A1 (en) * 2004-03-31 2005-10-27 Eli Lilly And Company 2-aryloxyethyl glycine derivatives and their use as glycine transport inhibitors
WO2006000222A2 (en) * 2004-06-24 2006-01-05 H. Lundbeck A/S The combination of an antipsychotic and a glycine transporter type i inhibitor for the treatment of schizophrenia
ES2412384T3 (es) * 2006-07-18 2013-07-11 Astellas Pharma Inc. Derivado de aminoindano o sal del mismo
MX2009001869A (es) * 2006-08-30 2009-03-02 Hoffmann La Roche Inhibidores de glyt-1.
US20100083581A1 (en) * 2007-06-18 2010-04-08 Mattice Douglas A Environmental brush seal
MX353752B (es) 2009-01-20 2018-01-26 Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct Los ácidos sórbico y benzoico y sus derivados aumentan la actividad de un neurofármaco.
EP2380595A1 (de) 2010-04-19 2011-10-26 Nlife Therapeutics S.L. Zusammensetzungen und Verfahren zur selektiven Abgabe von Oligonukleotidmolekülen an spezifische Neuronentypen
US9700563B2 (en) * 2012-09-06 2017-07-11 MediSynergies, LLC Kappa opioid receptor compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1166711A (en) * 1966-03-28 1969-10-08 Kefalas As Process for the Preparation of Phenyl-Indane and -Tetralin Derivatives
US3549656A (en) * 1967-12-28 1970-12-22 Kefalas As Antidepressant 1 - aminoalkyl - thiophthalanes and acid addition salts thereof
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
US5225323A (en) 1988-11-21 1993-07-06 Baylor College Of Medicine Human high-affinity neurotransmitter uptake system
WO1993010228A1 (en) 1991-11-12 1993-05-27 Synaptic Pharmaceutical Corporation Dna encoding a glycine transporter and uses thereof
US5824486A (en) 1996-05-31 1998-10-20 Allelix Neuroscience Inc. Glycine transporter-transfected cells and uses thereof
US6008015A (en) 1997-04-11 1999-12-28 Allelix Neuroscience Inc. Glycine transporter
AR021509A1 (es) * 1998-12-08 2002-07-24 Lundbeck & Co As H Derivados de benzofurano, su preparacion y uso
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
US6566550B2 (en) * 2001-06-21 2003-05-20 Pfizer Inc Substituted aromatic ethers as inhibitors of glycine transport

Also Published As

Publication number Publication date
NZ523720A (en) 2004-07-30
AU2001281740B2 (en) 2006-02-16
DE60110914D1 (de) 2005-06-23
ES2238466T3 (es) 2005-09-01
DE60110914T2 (de) 2005-10-27
EA005621B1 (ru) 2005-04-28
HUP0302778A2 (hu) 2003-12-29
NO20030243D0 (no) 2003-01-17
BR0113011A (pt) 2003-07-01
KR20030015889A (ko) 2003-02-25
ATE295844T1 (de) 2005-06-15
IL153988A0 (en) 2003-07-31
IS6693A (is) 2003-01-20
MXPA03000642A (es) 2003-06-06
SK2022003A3 (en) 2003-06-03
HRP20030053A2 (en) 2005-02-28
JP2004504393A (ja) 2004-02-12
CZ2003396A3 (cs) 2003-05-14
CN1662519A (zh) 2005-08-31
BG107530A (bg) 2003-09-30
PL364439A1 (en) 2004-12-13
ZA200300514B (en) 2004-08-20
UA75081C2 (en) 2006-03-15
HUP0302778A3 (en) 2005-02-28
PT1301502E (pt) 2005-09-30
EP1301502B1 (de) 2005-05-18
CA2416447A1 (en) 2002-01-31
WO2002008216A1 (en) 2002-01-31
EP1301502A1 (de) 2003-04-16
AU8174001A (en) 2002-02-05
AR032358A1 (es) 2003-11-05
EA200300180A1 (ru) 2003-06-26
US20030181445A1 (en) 2003-09-25
US6921774B2 (en) 2005-07-26
IL153988A (en) 2006-10-05
CN100509791C (zh) 2009-07-08

Similar Documents

Publication Publication Date Title
NO20026010D0 (no) Substituerte quinazolinderivater og deres anvendelse som inhibitorer
DK1268431T3 (da) 3-Cyanoquinoliner, 3-cyano-1,6-naphthyridiner og 3-cyano-1,7-naphthyridiner som proteinkinaseinhibitorer
ATE524441T1 (de) Vla-4-inhibitoren
NO20042719L (no) Substituerte 2-amino-cykloalkankarboksamider og deres anvendelse som protease-inhibitorer
NO20030867D0 (no) Hydroksamderivater anvendelig som deacetylaseinhibitorer
DK1246802T3 (da) 4-aminopicolinater og deres anvendelse som herbicider
DK1347955T3 (da) Nye mandelsyrederivater og deres anvendelse som throbin-hæmmere
CY2012007I2 (el) Πεπτιδομιμητικοι αναστολεις πρωτεασης
NO20024997D0 (no) 2-guanidino-4-arylkinazoliner som NHE-3-inhibitorer
NO20031482L (no) Nye tiadiazoler og oksadiazoler, og anvendelse derav som fosfodiesterase-7inhibitorer
NO20030135L (no) Piperidinforbindelser for anvendelse som CCR-3-inhibitorer
DK1272488T3 (da) Tri-aryl-substitueret ethan-PDE4-inhibitorer
NO20035328D0 (no) Nye forbindelser og preparater som katepsinhibitorer
NO20040996L (no) Nye forbindelser og sammensetninger som catepsin-inhibitorer
NO20030243D0 (no) Nye forbindelser og deres anvendelse som glysintransportinhibitorer
DK1150996T3 (da) Nye amidinobenzylaminderivater og deres anvendelse som thrombin-inhibitorer
NO20013853D0 (no) Heteroarylamidiner, metylamidiner og guanidiner som proteaseinhibitorer
NO20025504D0 (no) Nye tiokromanderivater og anvendelse derav som trombininhibitorer
NO20030813L (no) Bifenylderivater og deres anvendelse som integrininhibitorer
NO20025786D0 (no) Protaseinhibitorer
NO20026164D0 (no) Benzoksazepinoner og deres anvendelse som squalen syntase inhibitorer
NO20023951D0 (no) Arylpiperaziner og arylpiperidiner og deres anvendelse som metalloproteinaseinhiberende midler
NO20023893D0 (no) Aminosyreforbindelser og deres anvendelse som NEP-, ACE- og ECE-inhibitorer
NO20025281D0 (no) Peptid-deformylase-inhibitorer
NO20025005D0 (no) Proteaseinhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application